Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Early Cardiac Rehab Safe, Feasible For Critically Ill Hospitalized ADHF PatientsAmong critically ill patients with acute decompensated heart failure (ADHF), initiating an early cardiac rehabilitation (CR) program is feasible, safe and may improve physical function, according to a randomized clinical trial published July 30 in JAMA Network Open.
- Use of HEPA Purifiers at Home Can Significantly Reduce SBPUsing portable high-efficiency particulate air (HEPA) purifiers at home can significantly lower systolic blood pressure (SBP) in adults with elevated baseline readings, even in areas with relatively low overall air pollution levels, according to a study published Aug. 6 in JACC.
- New Concise Clinical Guidance Addresses Evaluation and Management of PericarditisThe ACC’s newest Concise Clinical Guidance (CCG) expert consensus statement focuses on diagnostic and therapeutic advances in evaluating and managing pericarditis, with the goal of helping to close the educational gaps surrounding this condition for providers, payers and patients.
- Low SGLT2i Use Among Patients With HF in the Ambulatory Setting | NCDR StudyThe majority of ambulatory patients with heart failure (HF) eligible for SGLT2 inhibitor therapy did not receive it, despite increasing rates of SGLT2 inhibitor use in this patient population and high variability across sites, according to a study recently published in JAMA Cardiology.
- A Dynamic Model to Estimate Bleeding Risk Post PCI | NCDR StudyA dynamic model to estimate risk of major bleeding after PCI, trained and validated using data from the ACC's CathPCI Registry, exhibited less predictive error than static risk prediction models, according to a recent study published in PLOS Digital Health.